MK
Mani Kumar Allada
About Mani Kumar Allada
Data last updated:
Mani Kumar Allada is an Additional Director at Manishka Consulting Private Limited (since 2025) and Director at Quantikwa Pharma Private Limited (since 2025). The largest current company by reported revenue is Manishka Consulting Private Limited at ₹2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Manishka Consulting Private Limited U78300TS2023PTC179476 | Additional Director | 18 Jan 2025 | 2023 | ₹2 Lakh (FY 2024) | Active |
| Quantikwa Pharma Private Limited U21001AP2025PTC121678 | Director | 14 Oct 2025 | 2025 | Active |
Board colleagues of Mani Kumar Allada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavani Sesha Padma Allada | 10409207 | Manishka Consulting Private Limited | Director |
| Mannepalli Vasanthi | 10409208 | Manishka Consulting Private Limited | Director |
| Venkata Subba Lakshmi Silpa Mannepally | 08742036 | Quantikwa Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mani Kumar Allada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mani Kumar Allada
Mani Kumar Allada currently holds 2 directorships: Manishka Consulting Private Limited (Additional Director, since 18 Jan 2025, revenue ₹2 Lakh (FY 2024)); Quantikwa Pharma Private Limited (Director, since 14 Oct 2025).
Mani Kumar Allada was first appointed on 18 Jan 2025 as Additional Director at Manishka Consulting Private Limited.
The current boards of Mani Kumar Allada's companies include Bhavani Sesha Padma Allada (Manishka Consulting Private Limited), Mannepalli Vasanthi (Manishka Consulting Private Limited), Venkata Subba Lakshmi Silpa Mannepally (Quantikwa Pharma Private Limited).